Investment Banks Downgrade Bruker on Resignation of CFO | GenomeWeb

NEW YORK (GenomeWeb) – Investment banks Mizuho Securities and William Blair today downgraded Bruker's shares, following the company's announcement that CFO Charles Wagner is resigning effective June 12. 

Mizuho downgraded Bruker to a Neutral rating from a previous Buy rating, while William Blair downgraded the firm to Market Perform from Outperform. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.